A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free ß-human chorionic gonadotropin and pregnancy-associated plasma protein-A.

Saved in:
Bibliographic Details
Title: A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free ß-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Authors: Spencer, K., Souter, V., Tul, N., Snijders, R., Nicolaides, K. H.
Source: Ultrasound in Obstetrics & Gynecology. Apr99, Vol. 13 Issue 4, p231. 7p.
Database: Academic Search Ultimate
Description
ISSN:09607692
DOI:10.1046/j.1469-0705.1999.13040231.x